Status:
NOT_YET_RECRUITING
IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Rheumatoid Arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation and articular damage. Continuous medical research has dramatically improved the outcomes for patients ...
Eligibility Criteria
Inclusion
- Age is at leasr18 years old,
- established RA diagnosis according to 2010 the American College of Rheumatology/European League against Rheumatism classification criteria
Exclusion
- Associated autoimmune diseases,
- connective tissue diseases,
- chronic liver or kidney diseases or
- genetic diseases
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06558305
Start Date
September 1 2024
End Date
April 1 2025
Last Update
August 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.